IVIG Increased Platelet Counts in Patients with Covid-19 Vaccine-Related Clotting Disorder
Case study highlights 3 early VITT cases in Canada Treatment with high-dose intravenous...
Read MoreJun 10, 2021
Case study highlights 3 early VITT cases in Canada Treatment with high-dose intravenous...
Read MoreJun 9, 2021
Agency explains its controversial decision on a controversial drug FDA granted accelerated...
Read MoreJun 9, 2021
Injectable Tx for paroxysmal nocturnal hemoglobinuria available under REMS The FDA approved...
Read MoreJun 9, 2021
Electronic monitoring of Covid-19 symptoms wins high marks from patients In the 1980s the...
Read MoreJun 9, 2021
Schedule changes, asymptomatic screening, and other efforts needed to get kids back in the...
Read MoreJun 9, 2021
Traumatic or not, fractures in postmenopausal women increase risk of future fractures...
Read MoreJun 9, 2021
Neurodevelopmental outcomes at age 2 years did not differ by antiseizure medication exposures...
Read MoreJun 8, 2021
Lynne Peterson is the Senior Writer for Trends-in-Medicine.Here is the medical news to watch for...
Read MoreJun 8, 2021
Index intracerebral hemorrhage location and atrial fibrillation come into play After index...
Read MoreJun 7, 2021
Podcast key to editor’s undoing The voice of the American Medical Association—the JAMA...
Read MoreJun 7, 2021
But no significant results seen in overall COLCORONA cohort Colchicine had no statistically...
Read MoreJun 7, 2021
First new treatment for overweight/obesity since 2014 The FDA has approved semaglutide (2.4 mg...
Read MoreJun 4, 2021
But getting racial/ethnic minorities to pick up the phone is another problem The Los Angeles...
Read MoreJun 4, 2021
Improvements in motor complications persist Subthalamic nucleus deep brain stimulation (STN-DBS)...
Read MoreJun 4, 2021
Three-pronged system designed to assist early diagnosis The FDA authorized the Cognoa autism...
Read MoreJun 4, 2021
Nearly one-fifth of decedents had pathogenic/likely pathogenic gene variants, despite normal...
Read MoreJun 4, 2021
Overall survival and progression-free survival enhanced with 177Lu-PSMA-617 A novel agent that...
Read MoreJun 4, 2021
Manufacturer pulls products following reports of neurological events, death The FDA issued an...
Read MoreJun 4, 2021
Improved HbA1c levels, more time spent within target blood glucose range, less hypoglycemia...
Read MoreJun 3, 2021
Relatlimab add-on extended progression-free survival vs nivolumab alone Patients who were...
Read More